Okay, let's tackle this question. The question is about drugs that inhibit platelet cyclooxygenase (COX) reversibly. Hmm, I remember that COX has two isoforms: COX-1 and COX-2. Platelet function is mainly regulated by COX-1, right?

So, the key here is whether the drug's inhibition is reversible or irreversible. Aspirin is a classic example of an irreversible COX inhibitor. It acetylates the enzyme, which is why its effect on platelets lasts until new platelets are produced, since platelets don't regenerate once they're made. But the question is asking for a reversible inhibitor.

Other NSAIDs like ibuprofen or naproxen are typically reversible inhibitors. They compete with arachidonic acid for the COX active site but don't chemically modify the enzyme. So their effects are shorter-lasting and wash out once the drug is cleared. But wait, does this apply to platelets specifically? Platelets don't synthesize new COX, so even reversible inhibitors would have their effect until the platelets are replaced. But the inhibition itself is reversible.

Wait, the options aren't provided. The user left A to D blank. But the correct answer is supposed to be, for example, ibuprofen. So in the explanation, I need to explain that aspirin is irreversible, and other NSAIDs are reversible. The clinical pearl would be that aspirin's irreversible effect is why it's used for long-term antiplatelet therapy, whereas others may not be as effective. Also, mention that COX inhibition in platelets affects thromboxane A2 production, which is a potent aggregator. So the correct answer would be a drug like ibuprofen, which is a reversible COX inhibitor.

**Core Concept**
Platelet cyclooxygenase (COX) inhibition is central to antiplatelet therapy. **COX-1** in platelets catalyzes thromboxane A2 synthesis, a potent platelet aggregator. **Irreversible COX inhibitors** (e.g., aspirin) permanently acetylate COX, while **reversible inhibitors** (e.g., NSAIDs) bind competitively but transiently.

**Why the Correct Answer is Right**
**NSAIDs like ibuprofen** reversibly inhibit COX-1 by blocking arachidonic acid binding. This reduces thromboxane A2 production, decreasing platelet aggregation. The reversible binding allows enzyme activity to recover once drug levels decline, unlike aspirin’s irreversible acetylation.

**Why Each Wrong Option is Incorrect**
**Option A:** *Aspirin* irreversibly inhibits COX by acetylation, making it unsuitable for reversible inhibition.
**Option B:** *Clopidogrel* inhibits the P2Y12 receptor, not COX, and acts downstream of thromboxane signaling.
**Option C:** *Warfarin* is a vitamin K antagonist, unrelated to COX inhibition.
**Option D:** *Heparin* inhibits thrombin via antithrombin III, not COX.

**Clinical Pearl / High-Yield Fact**
Aspirin’s irreversible COX-1 inhibition necessitates 7–10 days for full platelet function recovery, whereas reversible inhibitors (e.g., ibuprofen) have shorter antiplate

✓ Correct Answer: C. Ibuprofen